Document Detail


Acute-phase reactants and coronary heart disease.
MedLine Citation:
PMID:  16222631     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Inflammation is considered to play an essential role in the initiation, progression, and the final pathophysiological steps of atherosclerosis, plaque erosion or fissure, and eventually plaque rupture. Prospective studies have identified several markers of systemic inflammation that are predictors of future cardiovascular events, not only in apparently healthy subjects, but also in patients with unstable angina and previous myocardial infarction. Measurement of inflammatory markers may add to the predictive value of total and high-density lipoprotein cholesterol in assessing coronary risk long-term. Various biological mechanisms exist that could explain the pathological effects of these inflammatory molecules. Finally, the results from recent clinical trials indicate that the net benefit of various compounds in primary and secondary prevention of coronary heart disease, like aspirin, statins, and ACE inhibitors, may be mediated, at least in part, by modifying the consequences of the inflammatory response on vascular risk. However, further studies are required to address these associations because the mechanisms that cause an inflammatory response are only incompletely understood and deserve further investigation.
Authors:
Wolfgang Koenig; Robert S Rosenson
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Seminars in vascular medicine     Volume:  2     ISSN:  1528-9648     ISO Abbreviation:  Semin Vasc Med     Publication Date:  2002 Nov 
Date Detail:
Created Date:  2005-10-13     Completed Date:  2005-11-08     Revised Date:  2005-11-17    
Medline Journal Info:
Nlm Unique ID:  100940307     Medline TA:  Semin Vasc Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  417-28     Citation Subset:  IM    
Affiliation:
Department of Internal Medicine II-Cardiology, University of Ulm Medical Center, Ulm, Germany. wolfgang.koenig@medzin.uni-ulm.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acute-Phase Proteins / adverse effects,  immunology*
Arteriosclerosis / immunology
Blood Sedimentation
Blood Viscosity / immunology
Coronary Disease / immunology*
Humans
Leukocytes / immunology
Myocardial Ischemia / immunology
Chemical
Reg. No./Substance:
0/Acute-Phase Proteins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Infective agents and cardiovascular disease.
Next Document:  Hemostatic and rheological variables and risk of cardiovascular disease.